GW679769 oral tablets

DRUG2 trials

Sponsors

GlaxoSmithKline

Conditions

Incontinence, Urinary and Urinary Bladder, OveractiveNonulcer DyspepsiaOveractive Bladder

Phase 2

A Study Of GW679769 Compared To Placebo In Women With Overactive Bladder

CompletedNCT00321477

GlaxoSmithKlineIncontinence, Urinary and Urinary Bladder, Overactive, Overactive Bladder

Start: 2005-12-31End: 2007-02-28Target: 160Updated: 2017-01-20

An Exploratory Study Examining The Effects Of Taking GW679769 Once-Daily For 4 Days In Patients With Functional Dyspepsia

CompletedNCT00358410

GlaxoSmithKlineNonulcer Dyspepsia

Start: 2006-01-31End: 2006-08-31Updated: 2017-02-08